Filing Details
- Accession Number:
- 0000950170-23-068442
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-06 08:00:04
- Reporting Period:
- 2023-12-04
- Accepted Time:
- 2023-12-06 08:00:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1856725 | Rani Therapeutics Holdings Inc. | RANI | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1869579 | Talat Imran | 2051 Ringwood Ave San Jose CA 95131 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2023-12-04 | 5,000 | $2.57 | 474,455 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Includes 12,343 shares held by VH Moll, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.